ArticleAntibodies (Basel, Switzerland)2023

An Antibody Targeting Fibroblast Activation Protein Simultaneously Fused to Interleukin-2 and Tumor Necrosis Factor Selectively Localizes to Neoplastic Lesions.

Eleonora Prodi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.